Mobile CRM Market 2022 | Present Scenario and Growth Prospects 2029

According to a new research study by Future Market Insights (FMI), the global mobile CRM market is estimated to value over US$ 26.2 Bn in 2022, up from US$ 13.5 Bn in 2021. Growth of mobile CRM market is underpinned by a slew of factors, spanning from evolving gears of technology to ubiquitous use of smartphones. Businesses, in order to adopt agility and dexterity as two of their core values, are counting on platforms that mobilize management of customer relationships. This, in turn, is likely to work in favor of mobile CRM market through 2029 and create new opportunities for the vendors to expand their offerings and reap profits.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9896

As per the report, with the growth of digitized workforces, real-time access to critical information is no longer a “nice to have” aspect, rather it is a necessity to foster streamlined operations. Modern businesses are placing customer satisfaction at the top of their priority list and are actively seeking fine-grained insights for their sales realms to access on the go. This, in turn, is preparing the grounds for high scale adoption of mobile CRM platforms across the globe through 2029. According to the report, ‘CRM on demand’ is one of the overarching trends introducing major reforms in the mobile CRM market, as enterprises are increasingly turning to cloud-based suites that promise immense flexibility and scalability.

mobile crm market

“Trends in the mobile CRM market space point to an ever-increasing end user preference for efficiency and reliability. Considering this, key vendors in the mobile CRM market space are pushing their limits and bringing out new innovations for weaving successful end user experiences”.

According to the research study, BFSI ranks among some of the early adopters of mobile CRM till 2021 and beyond, with revenues estimated to surpass US$ 3 Bn in 2022. However, retail units are likely to overtake BSFI as one of the significant spenders on mobile CRM solutions in the latter half of the assessment period, as the retailers are rapidly turning to mobile CRM platforms for streamlining the aspects of their sales funnels. Adoption of mobile CRM in healthcare is also estimated to pick pace through 2028, given that healthcare services worldwide are shifting their focus toward ‘value-based care’ models.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9896

Large enterprises are likely to lead the race of mobile CRM adoption, followed by medium enterprises, unveils the research study. As large and medium enterprises are pulling their socks up to positively engage customers and stay highly competitive, adoption of mobile CRM across these enterprises will most assuredly gain new heights. Revenue opportunities for vendors of mobile CRM market remain imminent, as sales personnel across organizations, regardless of their size, are vying to make informed decisions that are ‘data-driven’.

COVID-19 Crisis Analysis

The pandemic of 2020 completely changed the way businesses operated under the restrictions of the pandemic. The pandemic restricted the interaction of enterprises with their customers to a certain extent and in order to keep their customers more in touch, the pandemic saw a substantial increase in the adoption of CRM solutions and systems.

Use of technology by enterprises and customers rose substantially in the pandemic era. Mobile CRM solutions saw an increase in adoption as the need for accessing customer data from anywhere in the world has increased to create customer-specific marketing solutions.

Mobile CRM solutions for businesses also saw an increase in innovations and increase in the integration of intuitive new technologies like AI and machine learning to make these CRM mobile apps more productive.

Demand for mobile-friendly CRM is anticipated to rise at a high pace in the post-pandemic era as more small businesses adopt CRM solutions to cater to their customers.

‘Pay-Per-Use’ Pricing Model: A Strategy Winning Over End Users

Considering the dynamicity of end user preferences, key vendors in the mobile CRM market are largely focused on R&D investments for unceasing developments. As price follows efficiency as the second-most important factor dictating purchase decisions, vendors are offering flexible ‘pay per use’ pricing models, as end-use preference for flexible pricing is causing a distant move away from subscription models.

Acquisitions and partnerships will continue being a vital part of the growth strategies of market players. For instance, in February 2021, AMDOCS announced its acquisition of Vubiquity, a leading firm offering premium digital content services and technology solutions. This acquisition was aimed at adding premium content capabilities, which include licensing, processing, and delivery, and positioning AMDOCS at the center of increased convergence across content community and video distributors.

Key Questions Answered in the Report

  • How is demand for mobile CRM expected to progress from 2022 to 2029?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9896

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Granola Market Overview, Future Trends, Market Segmentation, Opportunities 2022-2027

Granola is basically a breakfast food containing rice, oats etc. seeds and sweeteners, dried fruits, honey and oil, toasted until crunchy. Granola is taken as breakfast cereal or snacks as it consists of whole grain oat, as it is healthy and indulgent with essential vitamin and nutrients. It has high fiber content is a predominant feature across many markets.

There are various brands offering products with high level of fiber which supports weight maintenance, appetite suppression and digestive health and other healthy ingredients are also combined, such as vitamin and minerals, omega 3. Granola can often combine with yogurt, honey, strawberries, bananas, and other types of fruit or also can be mixed with other types of cereals so the nutritive value will increase.

Click on the link to get Report Brochure : https://www.futuremarketinsights.com/reports/brochure/rep-gb-4164

It is extremely popular snack food and breakfast with health benefits, as granola has ability to lower blood pressure, lower cholesterol, aid in weight loss attempts, regulate digestion and improve heart health problems,  improve skin quality, , it increases energy, manages diabetes prevent anemia, promote organ function, helps in building stronger bones and even prevent cancer.

Moreover, consumers who exercise likes to eat granola nutrition bars as it indicates that meal replacements and diet bars are used by health-minded consumers to manage balance nutrition and weight, and complement active lifestyles which provide beneficial fats.

Granola Market: Segmentation

Granola market is segmented on the basis of cereals, forms, usage, flavor, and distribution channel. On the basis of cereals, granola market is segmented as oats, brown rice, millet, buckwheat and quinoa. As oats are considered healthy oat granola segment has captured significant market shares, followed by quinoa and brown rice.

Granola market is further segmented on the basis of forms in cereals and bars.  The bar segment is being popular as preferred as meal replacement by regularly exercising, health conscious consumers.

On the basis of usage or applications, the market is segmented in breakfast baked goods, salads, gratins, fruit crisps, puddings, cookies, trail mix, cupcakes. Growing market demand for health cupcakes, cookies and other bakery products as well as healthy salads, driving market growth for granola based foods.

On the basis of flavors, the market is segmented in coconut, chocolate, banana, vanilla, strawberry and others. On the basis of distribution channel, the granola market is segmented into supermarket/ hypermarket, convenience stores, online and grocery stores.

Granola Market: Region wise outlook

Depending on regions, global granola market is segmented as: North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific Excluding Japan, Japan, and Middle East & Africa.

North America dominated the granola market, followed by Europe. The Demand of granola is rising in developing regions such as Asia Pacific Excluding Japan.

Asia- Pacific market is projected to witness the fastest growth during the forecast period.

Granola Market: Drivers

Increasing number of health conscious consumers will drive the market during the forecast period, due to various health benefits such as, it helps as aid in digestion and diabetes management, effective in reducing harmful LDL cholesterol, provides relief from constipation, heartburn and excess flatulence etc. Changing lifestyle of the consumer, increasing health consciousness and wellness are another major market drivers of granola as it is healthy snack and breakfast option.

Increasing disposable income, strengthen the purchasing power of consumer goods which includes nutritious food such as nutrition bars, snacks and cereal. Since the employment make the lives busier, the demand for nutrition bars and meal replacement could rise. As consumers consumes wholesome and nutritious food as they are easy on-the go.

Increasing competition from the variety of categories results that snack, cereal and bars companies will clearly define the addition of functional and nutritional benefits that set them apart from competing products.

Granola Market: Key players

Some of the key players in granola market are sunnycrunch, Kellogg Corners, General Mills, Nature Valley, Kraft Foods Inc., ConAgra foods, Nestlé, Slim-Fast Food Co. (a Unilever Company), Clif Bar & Coand others.

The report covers exhaustive analysis on:

  • Granola Market Market Segments
  • Granola Market Dynamics
  • Historical Actual Market Size, 2013 – 2014
  • Granola Market Size & Forecast 2015 to 2024
  • Granola Market Supply & Demand Value Chain
  • Granola Market Current Trends/Issues/Challenges
  • Granola Market Players Competition & Companies involved
  • Granola Market Technology
  • Granola Market Value Chain
  • Granola Market Drivers and Restraints

Regional analysis for Granola Market includes

  • North America
    • U.S. & Canada
  • Latin America
    • Brazil, Argentina & Others
  • Western Europe
    • EU5
    • Nordics
    • Benelux
  • Eastern Europe
  • Asia Pacific
    • Australia and New Zealand
    • Greater China
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Japan
  • Middle East and Africa
    • GCC Countries
    • Other Middle East
    • North Africa
    • South Africa
    • Other Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

To remain ahead, request complete TOC of this report – https://www.futuremarketinsights.com/toc/rep-gb-4164

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Balloon Catheter Market 2021: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2031

According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031. This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).

Drug eluting balloons are playing an important role by facilitating the push mechanism, through the drug treatment. Excipient coated balloons offer a high efficacy and viability for the transfer of the drug.

Development in such technologies is increasing the use of balloon catheters, boosting the market. Hence, to gain competitive edge, key players are developing advanced drug eluting balloon.

Subsequently, these companies are getting approvals from the governments to commercially manufacture these balloons. This is expected to bode well for the growth in the market.

Furthermore, due to prolonged stay at the hospital in angioplasty procedures, preference for the same is decreasing among patients with coronary artery disease (CAD). Hence, with attributes such as minimal invasion of drug eluting balloon catheters, demand is increasing among CAD patients.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1916

Hence, efforts are being taken by public authorities, NGO’s, and government to spread awareness regarding the positive benefits of balloon catheters. For instance, campaigns such as “Spread the Word Campaign”, educating women on CAD and its treatments solutions by Healthy Women and National Association for Nurse Practitioners.

A slew of such activities are expected to increase the demand for balloon catheters over the forecast period.

Key Takeaways

  • By product, normal balloon catheter holds the maximum share of 43.9% in 2021, expanding at 0.8% CAGR during the forecast period.
  • By indication, coronary artery disease is anticipated to account for nearly 71.5% market share in terms of value due to the high prevalence of coronary artery diseases across the globe
  • By raw material, the nylon segment holds 46.3% of the market share, registering 4.0% CAGR  in 2021
  • Polyurethane catheters are expected to hold second-largest share, contributing 34% of overall sales in 2021.
  • By end user, the hospital segment will account for 70.5% of the market share in 2021 due to the availability of advanced technology and need for minimally invasive surgical procedures.
  • By region, North America held the largest share of 31.7% in the global Balloon Catheter market in 2021.

Who is winning?

Some of the leading manufacturers of balloon catheters market are focusing on product launches for expansion of their product portfolio. They are also aiming for strategic mergers and partnerships, thereby, strengthening their global presence.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1916

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Disposable Laparoscopic Instruments Market size, Insights, Prospects, Growth Trends, Key Trends, Opportunities and Forecast until 2031

Future Market Insights (FMI) delivers key insights on the global disposable laparoscopic instruments market in its upcoming outlook titled “Disposable Laparoscopic Instruments Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028”.

In terms of value, the global disposable laparoscopic instruments market is projected to register a healthy CAGR of 5.7% during the forecast period due to various factors, regarding which FMI offers vital insights in detail. Increasing demand for minimally invasive procedures is expected to bolster the overall growth of the disposable laparoscopic instruments market globally.

The global disposable laparoscopic instruments market is segmented on the basis of product type, indication, end use and region. On the basis of product type, the market has been segmented into laparoscopic scissors, laparoscopic hooks, grasping forceps & dissectors, trocars, laparoscopic suction / irrigation devices and others. The trocars product segment is expected to register impressive CAGR of 5.4% during the forecast period.

Laparoscopy is a minimally invasive surgical technique performed through a keyhole incision. A small camera along with a light source attached to a tube enables surgeons to manoeuvre special disposable laparoscopic instruments to the target area and carry out the surgery.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-3166

This technique is mainly preferred for carrying out surgeries related to the pancreas, liver, colon and bile duct. The use of disposable laparoscopic instruments reduces the risk of infection during surgery.

Laparoscopic surgery refers to surgical procedures that are performed through one or multiple small incisions, rather than through a larger incision through the abdominal wall. The number of surgeries is increasing across the globe, more then 15–16 million laparoscopic surgeries are performed across the globe. This directly boosts the demand for disposable laparoscopic instruments as they are safe with no chances of infection. However, in the reusable laparoscopic instruments the chances for infection is high as the sterilization process is done manually in individual hospitals.

On the basis of indication, the market is segmented into general surgery, bariatric surgery, colorectal surgery, urology surgery, gynaecologic surgeries and others. Gynaecologic surgeries is expected to dominate the overall disposable laparoscopic instruments market throughout the forecast period. It is expected to witness to have US$ 2,122.7 Mn by 2028 end.

On the basis of end users, the global disposable laparoscopic instruments market is segmented into hospitals, ambulatory surgical centres and specialty clinics. In terms of end use, the hospitals segment is expected to witness high growth during the forecast period.

Reducing pricing for market pick up, awareness programs in emerging countries, growing demand for minimally invasive therapies and technological advancement are factors expected to drive the global disposable laparoscopic instruments market over the forecast period.

This report covers trends driving the growth of each segment and offers analysis and insights of the potential opportunities offered in the disposable laparoscopic instruments market in all regions of the world.

North America is expected to dominate the market throughout the forecast period. Foray of leading North American companies into the disposable laparoscopic instruments market over the last few years is a factor expected to boost the overall sale of these devices in the region.

In terms of value, APEJ is expected to witness significant growth during the forecast period. Significant investments in healthcare infrastructure, increasing patient pool along with increasing geriatric population in APEJ are factors expected to boost the revenue growth of the disposable laparoscopic instruments market in the region.

The key players in the global disposable laparoscopic instruments market include B. Braun Melsungen AG, Medline Industries, Inc., Stryker Corporation, Ackermann Instrumente GmbH, ASFS Medic’s company, Medino GmbH, Péters Surgical, Medtronic, Mediflex Surgical Products and Grena LTD.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3166

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Bone Growth Stimulators Market 2021: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2031

Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world. Some of the most common sites of osteoporotic fractures are the spine, wrists, hips, and shoulders.

Thus, the increasing population suffering from orthopaedic disease is creating high demand for bone growth stimulators. The cause of delayed bone healing and fractures is not known, however, it is creating a large economic impact on the market of bone growth stimulators.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-828

Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market. According to the latest research by FMI, the global bone growth stimulators market is expected to account for US$ 1,387.7 Mn by the end of 2029. The bone growth stimulators market is estimated to grow at a CAGR of 5.2% through the forecast period 2022-2028. However, factors such as the high prices of devices and product recalls are expected to hamper the growth of the bone growth stimulators market.

Over the past decades, spending on healthcare has grown globally. The growth of the emerging markets and increasing geriatric population in developed economies are among factors expected to boost healthcare spending, which is expected to subsequently expand the bone growth stimulators market. Increasing healthcare spending is expected to boost the demand for bone growth stimulators, which is, in turn, predicted to create high growth opportunities for players in the bone growth stimulators market over the forecast period.

Furthermore, the increasing number of fractures and technological advancements have increased non-invasive, and rapid technologies in the healthcare industry, which is boosting the bone growth stimulators market. Moreover, manufacturers are undertaking various efforts to provide bone growth stimulators that are more versatile and more convenient for patient use. According to the World Bank, around 1.25 million people get injured in road accidents, which leads to fractures and the requirement of fusion surgeries for their treatment every year. These are some of the prime factors that are expected to drive the global Bone growth stimulators market over the forecast period 2019-2029.

The North America bone growth stimulators market and Europe bone growth stimulators market combined are expected to hold a share of approximately 65% of the global bone growth stimulators market during the forecast period. This can be mainly attributed to the high adoption of advanced technology and reduced hospital visits.

Based on the product type, the global bone growth stimulators market has been segmented broadly into non-invasive bone growth stimulators and invasive bone growth stimulators. Non-invasive bone growth stimulators are also segmented into various other sub-segments such as Capacitive Coupling (CC) devices, Pulsed Electromagnetic Field (PEMF) devices, Combined Magnetic Field (CMF) devices, and ultrasound bone growth stimulators. The non-invasive bone growth stimulators segment is expected to hold a prominent share of the global bone growth stimulators market.

Based on applications, the bone growth stimulators market has been segmented into trauma injury & fractures, spinal fusion surgeries, and osteogenesis. In terms of revenue, the trauma injury and fractures segment dominated the global bone growth stimulators market in 2018. Based on the end user, the bone growth stimulators market is segmented into hospitals, homecare settings, orthopaedic clinics, and ambulatory surgical centres. The hospitals segment held the maximum share of the bone growth stimulators market in 2018, and is predicted to continue to dominate the market throughout the forecast period.

Some of the key players operating in the bone growth stimulators market are Zimmer Biomet Holdings Inc., Bioventus LLC, DJO Global, Orthofix Holdings, Inc., Ossatec Benelux Ltd., IGEA, and Ito Co., Ltd.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-828

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Esophagoscopes & Gastroscopes Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

Future Market Insights (FMI), in its recent in-depth analysis of the Esophagoscopes and Gastroscopes Market, underscores rising cases of gastrointestinal diseases and growing demand for minimally invasive surgeries as key push factors driving the adoption of esophagoscopes and gastroscopes. The research by FMI covers the current market size of the esophagoscopes and gastroscopes along with forecast analysis for the assessment period of 2022-2028.

The annual growth rate by 2028—rising for a modest 4.6 percent in 2022, is anticipated to stand at 5.3 percent. Analysis of the esophagoscopes and gastroscopes market also reveals an incremental opportunity of US$ 624.8 Mn between 2022 and 2028—surpassing US$ 1.5 Billion in 2028.  Furthermore, key advancements in healthcare technology driving superior innovations in medical devices with enhanced functionalities, will also contribute maximum revenues in the global esophagoscopes and gastroscopes market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-3120

The global esophagoscopes and gastroscopes market showcases a highly consolidated landscape, around 76 percent of which belongs to the top two companies- Olympus Corporation and PENTAX Medical Company.

“Tier 1 manufacturers of the global esophagoscopes and gastroscopes market, comprising Olympus Corporation and PENTAX Medical Company hold a lion’s share, whereas the remaining players contributed approximately 23.6% revenue share to the global market. While mergers and acquisitions and strategic collaborations are the expected key forward market strategies, technology transfer agreements will play a vital role in the overall growth of esophagoscopes and gastroscopes market”, explains the Practice Head, Healthcare & Medical Devices, Future Market Insights

Further competition analysis reveals that top-of-the-line product launches and more emphasis on the strengthening their presence in emerging economies of APAC, will be the key differentiating strategies. “Key players need to efficiently meet requirements of various end users including hospitals, ambulatory surgical centers, specialty clinics, and diagnostic centers, while ensuring customized services, with ease-of-use functionality and state-of-the-art technologies”.

Opportunities in Focus

  • Key participants in the global esophagoscopes and gastroscopes market are expected to benefit by exhibiting innovative product design that would further avoid cross contamination and enhance patient safety—specifically in developed economies.
  • Under-served patients in APAC’s developing economies, offer a substantial opportunity for medical devices manufacturers—who can leverage the expanding healthcare infrastructure. Moreover, medical expenditure by respective governments would enable installations sophisticated medical devices (endoscopes) in medical institutions, further increasing the demand for esophagoscopes and gastroscopes, in developing nations.

Considerable shift toward minimally invasive endoscopic procedures, is expected to have a significant impact on the overall growth of esophagoscopes and gastroscopes market. Key advantages including reduced blood loss, lower chances of infection, faster recovery, and fewer surgery marks have driven a lot of patients’ focus toward minimally invasive surgeries. Furthermore, faster recovery time and reduced risk of arterial fibrillation are some other critical factors supplementing to the adoption of minimally invasive procedures. The demand for minimally invasive procedures is thus likely to exhibit potential business opportunities for manufacturers of esophagoscopes and gastroscopes.

Ease in getting FDA clearances is a critical factor driving the sales of esophagoscopes and gastroscopes. Contained under the Modernization Act, exemption of devices that were subjected to certain restrictions has worked in the favor of device manufacturers who no longer need to submit premarket submissions and enable FDA to redirect resources. Such exemptions have significantly minimized the time taken for regulatory approval—thereby, reducing the cost of the devices and driving sales growth of esophagoscopes and gastroscopes.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3120

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

SGLT2 Inhibitors Treatment Market is looking forward to grow at a higher rate in the forecast period of 2021-2031

SGLT2 Inhibitors Treatment Market Overview

SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.

SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes across the globe is never-ending, thus leading to grow the market. The prevalence of people suffering from Diabetes is said to lead the market at another level.

What is driving Demand for SGLT2 Inhibitors Treatment Market?

The demand for this market has seen at a higher rate at a global level as there has been increase in the number of Diabetic cases with increase in the population. According to WHO data worldwide, the count in the cases is seen at a higher side i.e. from 2.8% in 2000 and by 2030 it is said to be 4.4%. According to the 29.1 million cases of people diagnosing with diabetes in the year 2010.

The changing lifestyle, obesity and sedentary lifestyle can be the causes for diabetes can demand the SGLT2 market. Population preferring simple and easy way of treatment can boost the market. Covid 19 has eventually driven the market growth as post covid complications has made it a necessity.  In addition, new combination drugs seems to drive the market. US and Europe has the highest number of morbid obesity cases which leads to Diabetes, can be the driving factor for the market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14054

U.S. SGLT2 Inhibitors Treatment Market Outlook

  • North America occupies about 65% of the market share. US accounts for the highest number of type 2 diabetic cases owing to demand in the market growth. North America also has well established health a care structure. Canagliflozin saw an immense growth in the US, which was approved by US FDA. According the study on an average of 1.75 million US native is diagnosed with type 2 Diabetes, furthermore the population suffering from morbid obesity is one of the major reason to cause Diabetes. This gives us an open window to drive our market.

Europe Demand Outlook for SGLT2 Inhibitors Treatment Market

Empagliflozin is said to be the leading the market in Europe region and can be used in adults with low adverse effect. European commission has granted permission to market the product globally. EMPOWER program has been run so as to understand the efficacy of the Empagliflozin, this was brought in by Boehringer Ingelheim and Lilly.

Empagliflozon was the recent medicine to be approved by FDA in 2014. European Medicine Agency confirms that the SGLT 2 inihibitors can be used in treatment of Type 2 Diabetes. Europe has the highest rate of Diabetes cases which is fatal in nature and in the given forecast period it is said to reach an average of 10million cases.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-14054

Who are the Key Manufacturers and Suppliers of SGLT2 Inhibitors treatment market.

Some of the key players operating in the SGLT2 Inhibitors Treatment Market are

  • Eli Lilly and Company (The U.S),
  • C.H. Boehringer Sohn AG & Ko. KG (Germany),
  • Johnson & Johnson (The U.S),
  • AstraZeneca plc (UK),
  • The Merck Group (Germany),
  • Pfizer Inc. (The U.S),
  • Tecnimede Group (The U.S),
  • Unichem Laboratories Ltd. (India), and
  • Edifício Bluepharma (Portugal).

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

SGLT2 Inhibitors Treatment Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-14054

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Mucopolysaccharidosis (MPS) Treatment Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2031

A market study presented by FMI ‘ Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014-2021 and Opportunity Assessment 2022-2029,’ explains the significant factors influencing the current market structure.

According to research, the mucopolysaccharidosis treatment is still emerging, and different geographies have implemented standard treatment options for the condition. However, there is no universally accepted treatment pattern for mucopolysaccharidosis. Mucopolysaccharidosis falls under rare diseases, which is a complex, diverse, constantly evolving field, and there is a significant shortage of medical and scientific data related to it. Mucopolysaccharidosis treatment and diagnosis involves complex managing requirements, which include long-term care, rehabilitation support, and a continuous treatment plan.

Research Activities Uplift Stem Cell Therapy Application in MPS Treatment

In the present scenario, the drugs that are considered for mucopolysaccharidosis treatment, such as aldurazyme, naglazyme, vimizim, elaprase, mepsevii and hunterase, are the only regulated and recommended drugs present in the market. These drugs fall under enzyme replacement therapies, however, with present research initiatives for stem cell therapies, the latter is considered a prominent mucopolysaccharidosis treatment. Clinical research shows that stem cell transplantation covers a large area that is not covered with the more frequently recommended practice of enzyme replacement therapies, which changes the current market structure for mucopolysaccharidosis treatment, prioritising the latter.

Stem cell therapy is a therapeutic option for mucopolysaccharidosis patients suffering from a severe phenotype, as research shows the method can preserve neurocognition or can even help break the progressive neurodegeneration. The method is provided with strict selection criteria, which is followed by maintained regulations. Research shows that stem cell therapy as a treatment option is gaining popularity among healthcare professionals for mucopolysaccharidosis treatment, which can be attributed to the relation of its better reach towards a normal health condition for the patient.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5880

Enzyme Replacement Therapy Remains Lucrative for Market Investors

As per further assessments of the mucopolysaccharidosis treatment market, it has been difficult to collect epidemiological data pertaining to rare diseases, especially mucopolysaccharidosis treatment, which is likely to impede the actual estimation of the economic burden associated with the condition. The cost estimation for each mucopolysaccharidosis treatment type is affecting and, in turn, creating a more vulnerable situation for the businesses and disrupting research & development activities for each company.

Enzyme replacement therapy is the most attractive segment for investors, however, the unavailability of reimbursement plans and precise treatment plans is encouraging most patient in developing regions to opt for symptomatic treatments instead of enzyme replacement therapy, which is still considered to be the standard mucopolysaccharidosis treatment.

Key Players Focus on Clinical Research of Treatment Models

The report segments the mucopolysaccharidosis treatment market into seven regions to elaborate on the regional trends pertaining to the treatment plan. Major players are focusing on increasing their market share in the Asia Pacific market through strategic collaborations with regional research institutes. There is a lack of awareness about rare diseases among the general public as well as in medical healthcare facilities in several emerging economies. According to a survey and industry report, it takes patients in the US an average of 7.6 years and patients in the UK an average of 5.6 years to actually receive a proper diagnosis. Moreover, it involves a team of healthcare professionals to actually get the right mucopolysaccharidosis treatment and diagnosis pattern for reported cases.

Manufacturers are in the process of introducing a considerable number of mucopolysaccharidosis treatment options, which are currently under clinical trials. An estimated 160 and above clinical trials are being performed for mucopolysaccharidosis treatment. Thus, ensuring that the manufacturers take this mucopolysaccharidosis treatment market to be lucrative and potential rich in terms of revenue. Medical research institutes play an important role in this particular market. They are expected to be the bridge between treatment plans and economical solutions for manufacturers, thus leaving an explicable and lucrative model for mucopolysaccharidosis treatment.

The mucopolysaccharidosis treatment market includes companies such as BioMarin Takeda Pharmaceutical Company Limited, Sanofi S.A., and Ultragenyx Pharmaceutical Inc. BioMarin accounts for a significant value share in the present mucopolysaccharidosis treatment market. The currently existing promising drug types are expected to face competition from emerging candidates. In addition the mucopolysaccharidosis treatment products of other companies, such as Sangamo Therapeutics, Inc., REGENXBIO Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., and others, are also in the pipeline.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5880

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Sulfur Hexafluoride Market Pegged at 5.8% CAGR over the forecast period 2029

The global sulfur hexafluoride market is poised for promising growth at a projected CAGR of approximately 5.8% during the course of forecast period (2019-2029). Favourable chemical properties and variegated end-use applications particularly electronic devices continue to supplement the growth of sulfur hexafluoride market.

Moreover, the medical applications of sulfur hexafluoride are gaining traction in recent years. For instance, sulfur hexafluoride is extensively being used for non-invasive surgeries to examine the cause and location of the ailment. Hence, medical applications are significant contributors to the growth of sulfur hexafluoride market.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-11177

Key Takeaways of Sulfur Hexafluoride Market Study

  • Role of sulfur hexafluoride in developing electronic circuits is the growth engine of the market.
  • Chemical inertness, non-toxicity, high density, and high dielectric strength are highly sought-after attributes of sulfur hexafluoride.
  • Electronic grade sulfur hexafluoride contributes substantially to the overall demand.
  • Asia Pacific carves out approximately 45.8% revenue share in the global sulfur hexafluoride market.
  • Europe will exhibit relatively sluggish market growth owing to stringent government regulations.

Key players must adopt multipronged strategies such as joint ventures and product development for competitive leadership. These strategies are fundamental to fortifying their foothold in the global sulfur hexafluoride market.

sulfur hexafluoride market share analysis by region
Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-11177

Asia Pacific Accounts for 45.8% Share in Sulfur Hexafluoride Market

On account of enormous regional population, power and energy demand is soaring in Asia Pacific. Being a leading end-use application of sulfur hexafluoride, power & energy generation industry is supporting the growth of regional market. Hence, Asia Pacific sulfur hexafluoride market garnered approximately 45.8% market share in 2018.

The sulfur hexafluoride market is Europe will relatively be slow during the forecast period owing to environmental implications associated with the product. Moreover, stricter norms set down by governing bodies are limiting the sulfur hexafluoride market growth in the region. However, improved sustainable practices in certain domestic markets such as the United States will contribute to steady market growth in the country.

Sustainable Practices Remain Key Agenda of Industry Leaders

Some of the key players featured in this FMI study include, but are not limited to, Advanced Specialty Gases, Air Liquide, Electronic Fluorocarbons, LLC, Axcel Gases, American Gas Products, Solvay S.A., Praxair Technology, Inc., Honeywell International, Fujian Shaowu Yongfei Chemical Co. Ltd., Air Products and Chemicals, Inc., Chengdu Kemeite, Concorde Specialty Gases Inc., and Liming Research Institute.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/11177

The global sulfur hexafluoride market is fragmented in nature.  Reusing sulfur hexafluoride and incorporating latest technology is the key forte of market leaders. For instance, Solvay reclaims and reuses sulfur hexafluoride gas worldwide to comply with stringent environmental norms. Other players opt for collaborations to strengthen their market presence.

More about the Report

FMI’s study offers an in-depth market forecast and analysis on the global sulfur hexafluoride market. The major categories encompassed by the report include grade (technical, electronic), application (electrical transmission and distribution, semiconductor manufacturing) across five regions (North America, Latin America, Europe, Middle East & Africa, Asia Pacific).

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Neurovascular Guidewires Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2031

The global demand for neurovascular guidewires will reach the valuation of nearly US$ 280 million in 2022, witnessing an estimated increase of 3.6% over 2022. Over 2022-2028, the global neurovascular guidewires market revenue is likely to expand 1.5X.

According to a new research study of Future Market Insights,

  • Straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in neurovascular guidewires market through 2028.
  • Aneurysms and intra-and extra-cranial angioplasty reflect highest applicability of neurovascular guidewires.
  • Hospitals, though anticipated to reflect limited investment opportunities in the neurovascular guidewire market, will remain the leading end-use segment with the maximum share in terms of revenue generation.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-3121

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires market. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue. Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies pertaining to the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires market as the patients are not required to pay from their own pocket.

FMI’s report tracks some of the key companies operating in the neurovascular guidewire market, which include Boston Scientific Corporation, Medtronic, Penumbra Inc., Stryker, Asahi Intecc Co. Ltd, Integer Holding Corporation, Cordis Corporation, CONMED Corporation, phenox GmbH, and Integer Holding Corporation, among others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3121

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com